Exploring Knowles Corporation (KN) Investor Profile: Who’s Buying and Why?

US | Technology | Communication Equipment | NYSE

Knowles Corporation (KN) Bundle

Get Full Bundle:
$9 $7
$9 $7
$9 $7
$9 $7
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

You're looking at Knowles Corporation (KN) and asking the right question: who is buying this stock right now, and what exactly is their thesis? Honestly, the investor profile is clear: this is an institutional play, with major firms like Blackrock and Vanguard Group Inc. collectively holding over 96% of the stock. Why the conviction? It's a bet on the company's successful pivot away from volatile consumer electronics and into high-margin specialty markets like MedTech and Defense. We saw the results of this focus in the third quarter of 2025, where the company reported revenue of $152.9 million and non-GAAP diluted earnings per share (EPS) of $0.33, beating estimates. The Precision Devices segment, in particular, saw a strong 12% revenue increase, driven by demand in industrial and energy sectors, including a noteworthy $75 million alternative energy order. But still, with the stock trading at a high 50.5 times earnings, you defintely need to know if the growth story justifies the valuation. Let's break down the institutional moves and the core strategic drivers that analysts believe could push the stock toward its average price target of $27.00.

Who Invests in Knowles Corporation (KN) and Why?

The investor profile for Knowles Corporation (KN) is not what you might call a retail-driven stock. The short answer is that the company is overwhelmingly owned by large financial institutions, which means their investment thesis is focused on the long-term strategic shift and financial discipline, not short-term trading noise.

As of late 2025, institutional investors and hedge funds collectively own a staggering 96.35% of the company's stock. This leaves retail investors with a negligible stake, close to 0.00%. When you see this level of institutional concentration, you know the stock's movement is driven by massive, strategic capital flows, not individual sentiment. Insiders, like executives and directors, hold a modest but significant stake of around 2.54% to 3.68%, which is a good sign for alignment.

The Institutional Giants: Core Holdings and Active Plays

The investor base is dominated by index funds and massive asset managers. Firms like BlackRock, Inc. and Vanguard Group Inc. are among the largest shareholders. BlackRock, for example, holds a significant position, reflecting the stock's inclusion in various index and passively managed funds. This type of ownership tends to be sticky-it's a long-term, core holding that provides a stable floor for the stock price.

But it's not all passive. You also see active management at play. For instance, in recent quarters, firms like Ariel Investments LLC increased their stake, while others, such as Bank of New York Mellon Corp, slightly reduced their position. This constant churn indicates that while the core remains, active managers are making specific, conviction-based bets on the company's strategic roadmap.

  • BlackRock, Inc.: Holds a substantial position, often reflecting passive index tracking.
  • Vanguard Group Inc.: Another top holder, signaling long-term, diversified portfolio commitment.
  • Active Managers: Firms like Advantage Alpha Capital Partners LP are initiating new, multi-million-dollar positions.

Investment Motivations: Precision, Margins, and Growth

What's attracting these seasoned investors to Knowles Corporation? It boils down to a clear, high-margin strategic pivot. The company divested its lower-margin consumer electronics business and is now laser-focused on three high-growth, high-value segments: MedTech, Defense, Industrial, and Electrification/Energy. This is a classic move from a commodity player to a specialty component provider.

The numbers from the 2025 fiscal year tell the story. The company is guiding for full-year organic revenue growth of 6%, which is solid. More importantly, management has set aggressive, but achievable, targets that are music to an analyst's ears. They are aiming for an 8-10% annual revenue growth over the next five years, plus a significant push to increase EBITDA margins from a current 24% to a target of 30%.

The real opportunity here is the margin expansion. A 600-basis-point jump in EBITDA margin is a powerful lever for future earnings. This focus on high-reliability, custom-engineered products-like advanced medtech microphones and RF filters-is what makes the investment thesis compelling. It's a bet on essential, non-cyclical technology. If you want to dive deeper into the balance sheet strength that supports this strategy, you can check out Breaking Down Knowles Corporation (KN) Financial Health: Key Insights for Investors.

Strategies: Value, Growth, and Financial Engineering

The typical investment strategies seen among Knowles Corporation (KN) shareholders are a mix of value and growth-at-a-reasonable-price (GARP) plays, plus a nod to financial engineering.

Value/GARP Investing: Many investors are attracted to the strong balance sheet. Knowles maintains a robust financial position with net leverage below one, which is defintely a sign of stability. The company's trailing twelve months (TTM) revenue is around $0.56 Billion USD as of Q3 2025, with TTM EPS at $0.47. This shows a profitable, albeit transforming, business. The investment is predicated on the belief that the stock is undervalued relative to its future earnings power as the high-margin segments scale up.

Financial Engineering: The company is actively returning capital to shareholders, which is a key signal for institutional investors. They repurchased $55 million in stock this year alone, part of a larger program that has exceeded $200 million in buybacks over the past few years. Share buybacks reduce the share count, which directly boosts the earnings per share (EPS) for the remaining shareholders, even if net income stays flat. It's a clear action that enhances shareholder returns.

Here's the quick math on Q4 2025 guidance: With a non-GAAP diluted EPS range of $0.33 to $0.37, the market is looking for continued execution on the margin expansion plan. Any beat on the high end of that range will likely trigger a positive reaction from these institutional buyers, who are already positioned for the strategic turnaround.

Investor Type Approximate Ownership (2025) Primary Motivation
Institutional Investors 96.35% - 101.77% Long-term growth in MedTech/Defense, margin expansion to 30% EBITDA.
Retail Investors ~0.00% Personal research, general market sentiment (minimal impact).
Corporate Insiders 2.54% - 3.68% Alignment with shareholder value, long-term compensation.

The key action for you is to monitor the quarterly reports, specifically the margin progress in the Precision Devices and MedTech segments. That's where the real value creation is happening.

Institutional Ownership and Major Shareholders of Knowles Corporation (KN)

If you're looking at Knowles Corporation (KN), the first thing to understand is that it's defintely an institutional play. The vast majority of the company is held by large funds and asset managers, not individual retail investors. This concentration means their buying and selling dictates much of the stock's near-term movement, so tracking their activity is crucial for your investment thesis.

Overall, institutional investors hold approximately 96.35% of Knowles Corporation's stock, a remarkably high figure that signals professional conviction in the company's specialty electronic components business model. This level of ownership means the stock is highly sensitive to the quarterly portfolio adjustments of a few major players. It's an institutional darling.

Top Institutional Investors and Their Holdings

The top shareholders in Knowles Corporation are the usual suspects in the asset management world-firms that manage vast index and actively managed funds. As of the most recent filings (Q3 2025, ending September 30, 2025), BlackRock, Inc. and Vanguard Group Inc. lead the pack, which is typical for a mid-cap company included in major indices.

Here's a snapshot of the largest institutional stakes, based on their September 30, 2025, 13F filings:

Major Shareholder Shares Held (Q3 2025) Market Value ($ Millions) % of Total Shares Outstanding
BlackRock, Inc. 13,277,347 $316.96 15.73%
Vanguard Group Inc 10,953,728 $267.55 13.28%
Dimensional Fund Advisors Lp 5,781,904 $139.12 6.91%
Neuberger Berman Group LLC 5,019,922 $118.53 5.88%
Franklin Resources Inc 5,108,184 $109.16 5.42%

Recent Shifts in Institutional Stakes: Accumulation vs. Distribution

What really matters isn't just who owns the stock, but what they've done lately. The most recent quarter (Q3 2025) shows a mixed but generally active picture, which is what you want to see for liquidity and price discovery.

Some of the largest passive managers, like BlackRock, Inc., slightly trimmed their positions, selling about 121,338 shares, a modest decrease of 0.906%. Vanguard Group Inc. also reduced its stake by 354,564 shares. This is often routine rebalancing within index or large-cap funds, not a fundamental rejection of the company. On the other hand, active managers showed strong accumulation.

  • Neuberger Berman Group LLC boosted its holdings by a substantial 894,722 shares, signaling a clear conviction in the company's future.
  • Franklin Resources Inc. also added significantly, purchasing 484,500 shares.
  • Goldman Sachs Group Inc. increased its stake by 758,870 shares, a major vote of confidence.

The net result of this trading activity-passive trimming offset by active accumulation-suggests that while index funds are rebalancing, active investors are finding the valuation compelling, especially following the company's strong Q3 2025 earnings where they reported $0.33 EPS, beating consensus estimates of $0.25.

The Impact of Institutional Investors on KN's Strategy

With nearly all of the stock in institutional hands, these large investors play an outsized role in Knowles Corporation's stock price and corporate strategy. When a company has such high institutional ownership, management is acutely aware of what these shareholders want: consistent earnings, efficient capital allocation, and a clear growth roadmap.

Their influence can be seen in the company's recent actions, like the Q3 2025 capital management moves: Knowles managed cash flow effectively, enabling $20 million in share buybacks and a $15 million reduction in debt. These are direct actions to satisfy institutional demands for shareholder return and a stronger balance sheet. Furthermore, the presence of activist-style filings (Schedule 13D) from any major holder would signal a potential push for strategic change, though most current filings are passive (13G). This high ownership provides a stable base for the stock, but also means any collective shift in sentiment can lead to rapid price changes.

For a deeper dive into the company's fundamentals that these institutions are watching, you should review our detailed analysis: Breaking Down Knowles Corporation (KN) Financial Health: Key Insights for Investors. Your next step should be to monitor the next round of 13F filings in early 2026 to see if the active accumulation trend continues.

Key Investors and Their Impact on Knowles Corporation (KN)

You're looking at Knowles Corporation (KN) and seeing a stock with a strong institutional footprint, which is exactly what you'd expect from a company executing a focused industrial technology strategy. The direct takeaway here is that institutional investors-the big money-effectively control the stock, meaning their collective sentiment drives the price more than retail trading.

Honestly, this isn't a stock where you'll find a single, headline-grabbing activist investor dominating the narrative. Instead, the story is one of near-total institutional ownership, which sits at a staggering 96.35% of the outstanding shares. This level of concentration means the major funds act as a de facto steering committee for the company's capital allocation and long-term strategy.

Here's a quick look at the largest shareholders based on their most recent filings (as of September 30, 2025), which dictates the current investor profile:

Notable Investor Shares Held (as of 9/30/2025) Shares Change (Q3 2025)
Blackrock, Inc. 13,277,347 -121,338
Vanguard Group Inc. 10,953,728 -354,564
Dimensional Fund Advisors Lp 5,781,904 -98,021
Franklin Resources Inc. 5,108,184 +484,500
Neuberger Berman Group Llc 5,019,922 +894,722

The sheer size of these holdings-Blackrock, Inc. and Vanguard Group Inc. alone hold over 24 million shares-means their portfolio decisions create significant movement. When a fund like Vanguard rebalances a massive index fund, Knowles Corporation's stock price defintely feels it. Their influence is less about public battles and more about private pressure on management to deliver on key financial metrics like free cash flow and return on invested capital (ROIC).

Recent Moves: Who's Buying and What's the Signal?

The recent trading action shows a mixed but telling picture. On one hand, you have major institutional players like Franklin Resources Inc. and Neuberger Berman Group Llc adding substantially to their positions in the third quarter of 2025, buying 484,500 and 894,722 shares, respectively. This signals confidence in the company's shift toward its higher-margin Precision Devices and Medtech & Specialty Audio segments.

Plus, smaller but influential funds like Creative Planning boosted their stake by 26.9% in Q2 2025, which suggests a growing belief in the company's strategic direction. The buyers are essentially validating management's focus on specialty components for markets like medtech, defense, and industrial applications, which drove a 7% year-over-year revenue increase to $153 million in Q3 2025.

  • Buyers affirm the high-margin industrial pivot.
  • Sellers are likely rebalancing or taking profits after the Q3 earnings beat.

The Insider Perspective: A Note of Caution

But here's the reality check: you also saw significant insider selling very recently. Knowles Corporation's CEO, Jeffrey Niew, sold 98,252 shares for about $2.33 million on October 31, 2025. And just weeks later, on November 21, 2025, CFO John S. Anderson sold 30,000 shares for a total transaction value of $632,000.

While insider selling can be for personal financial planning, this concentration of executive sales-especially following a strong Q3 2025 non-GAAP diluted EPS of $0.33-is a signal you can't ignore. It suggests that, despite the positive near-term outlook (Q4 2025 revenue is projected to be between $151 million and $161 million), the people closest to the business may see the stock as fully valued at its current $1.8 billion market capitalization. What this estimate hides is whether this selling is a response to the stock's year-to-date performance or a deeper concern about the pace of future growth.

Investor Influence: Driving Capital Allocation

The primary way these large investors impact Knowles Corporation is by pushing for shareholder-friendly capital allocation (how a company spends its money). They want to see excess cash returned to them, and the company is delivering. In Q3 2025 alone, the company repurchased $20 million in shares and reduced debt by $15 million. This is a direct result of the institutional investor base rewarding cash flow management and a healthy balance sheet.

If you want to dig deeper into the company's operational performance that underpins these investor decisions, you should check out the detailed financial breakdown: Breaking Down Knowles Corporation (KN) Financial Health: Key Insights for Investors.

Market Impact and Investor Sentiment

You're looking at Knowles Corporation (KN) and trying to figure out if the big money is bullish or just holding on. The direct takeaway is that institutional sentiment is cautiously positive, underpinned by strong Q3 2025 financial performance, but tempered by significant insider selling. The market is pricing in the company's transformation, but you need to watch the insider moves defintely.

The investor base is overwhelmingly institutional, holding approximately 96.35% of the stock. This level of concentration signals that the long-term strategic narrative-moving away from consumer electronics toward higher-margin industrial and MedTech markets-is largely accepted by major funds. The top holders, including Vanguard Group Inc. and BlackRock, Inc., are essentially the bedrock of the stock, owning millions of shares.

  • Institutional ownership is near 96%.
  • Vanguard is a top shareholder, holding over 9.6 million shares.
  • Sentiment is positive on the strategic shift.

Recent Market Reactions: The Insider vs. Institution Split

The stock market's recent reaction to Knowles Corporation (KN) has been a study in conflicting signals. On one hand, the company reported a strong beat for the third quarter of 2025, with revenue hitting $153 million, a 7% year-over-year increase, and earnings per share (EPS) of $0.33, significantly topping the consensus estimate of $0.25. This news drove a positive market response, pushing the stock near its 52-week high of $24.53.

But here's the rub: high-level insider selling has created a headwind. In late 2025, CEO Jeffrey Niew sold 98,252 shares, netting about $2.33 million. Plus, CFO John S. Anderson sold another 30,000 shares for a total transaction value of $632,000 in November 2025. When insiders, who know the business best, are trimming their stakes, it gives pause to the market, even with strong earnings. This is a classic risk-reward tension.

You can see the long-term context of this shift in the company's foundation by reviewing Knowles Corporation (KN): History, Ownership, Mission, How It Works & Makes Money. The institutional buying continues, though. For example, Creative Planning boosted its position by 26.9% in the second quarter, adding 52,552 shares.

Analyst Perspectives on Key Investors' Impact

Wall Street analysts are generally optimistic, giving Knowles Corporation (KN) a consensus rating of Moderate Buy. The average price target sits around $27.00, with some firms like Robert W. Baird setting a target as high as $30.00. This confidence stems from the success of the strategic pivot, particularly the performance of the Precision Devices segment, which saw a 12% revenue increase due to strong demand in medtech, defense, and industrial markets.

The impact of key investors is twofold. First, the stability provided by large passive funds like Vanguard and BlackRock reduces day-to-day volatility. Second, active institutional buyers are validating the company's projected full-year 2025 organic revenue growth of 6%. They are buying into the future growth story, not just the current numbers.

Here's a quick look at the recent analyst targets and the company's latest performance:

Metric Value/Target (2025 Data) Source Date
Q3 2025 Revenue $153 million Oct 23, 2025
Q3 2025 EPS $0.33 Oct 23, 2025
Consensus Price Target $27.00 Nov 2025
Highest Price Target $30.00 (Robert W. Baird) Oct 24, 2025

What this estimate hides is the potential for a market rotation away from smaller-cap industrial tech if the broader economy slows. Still, the current outlook is strong, with Q4 2025 EPS guidance set between $0.330 and $0.370.

Next step: Check the next 13F filings for BlackRock and Vanguard to see if they are net buyers or sellers in Q4 2025.

DCF model

Knowles Corporation (KN) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.